The global vertebral compression fracture devices market is slated to grow at a 5.7 percent compound annual growth rate through 2022, based on an Allied Market Research report, according to medGadget.
Here are seven observations:
1. The market was worth $748 million in 2015, and is set to hit $1.1 billion by 2022.
2. The growing popularity of minimally invasive spine surgery and the increasing number of osteoporosis and arthritis will boost the VCF global market.
3. The potential of post-surgical complications and the presence of a strict regulatory approval process will pose as obstacles to market growth.
4. The balloon kyphoplasty devices segment will likely dominate the market, due to its success in decreasing back pain and reestablishing vertebral body height. The vertebroplasty segment will also witness growth during through 2022.
5. North America will continue to lead the global market, driven by the popularity of VCF devices and a spurt in the number of spinal procedures.
6. The Asia-Pacific region will grow at a 6.7 percent CAGR through 2022, due to enhanced healthcare infrastructure and growth in emerging market expenditures.
7. Key companies in the market include Alphatec, Benvenue Medical, DePuy Synthes, Globus Medical, Medtronic, Orthovita, Osseon, Stryker Corp., VEXIM and Zimmer Biomet.